|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.49 USD | -0.10% |
|
+1.35% | -28.88% |
| 02/06 | Daxor Says Received US Patent for Remote Blood Volume Monitor Technology | MT |
| 27/04 | 5,061,267 Common Stock of Daxor Corporation are subject to a Lock-Up Agreement Ending on 27-APR-2026. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Closed End Funds
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.46TCr | - | - | - | - | - |
| 1.2TCr | - | - | - | - | - |
| 894.77Cr | - | - | - | - | - |
| 770.81Cr | - | - | - | - | - |
| 749.14Cr | - | - | - | - | - |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
